Non-toxic ubiquitous over-expression of utrophin in the mdx mouse.

Non-toxic ubiquitous over-expression of utrophin in the mdx mouse.

Veure altres versions (1)

Duchenne muscular dystrophy (DMD) is an inherited, severe muscle wasting disease caused by the loss of the cytoskeletal protein, dystrophin. Patients usually die in their late teens or early twenties of cardiac or respiratory failure. We have previously demonstrated that the dystrophin related prote...

Descripció completa

Dades bibliogràfiques
Autors principals:	Fisher, R, Tinsley, J, Phelps, SR, Squire, SE, Townsend, E, Martin, J, Davies, K
Format:	Journal article
Idioma:	English
Publicat:	2001

Ítems similars

Non-toxic ubiquitous overexpression of utrophin in the mdx mouse.
per: Fisher, R, et al.
Publicat: (2000)

Prevention of pathology in mdx mice by expression of utrophin: analysis using an inducible transgenic expression system.
per: Squire, S, et al.
Publicat: (2002)

Up-regulation of utrophin alleviates the dystrophic phenotype in the mdx mouse heart
per: Sang, E, et al.
Publicat: (2000)

Daily treatment with SMTC1100, a novel small molecule utrophin upregulator, dramatically reduces the dystrophic symptoms in the mdx mouse.
per: Tinsley, J, et al.
Publicat: (2011)

Muscle structure influences utrophin expression in mdx mice.
per: Glen B Banks, et al.
Publicat: (2014-06-01)

Daily treatment with SMTC1100, a novel small molecule utrophin upregulator, dramatically reduces the dystrophic symptoms in the mdx mouse.
per: Jonathon M Tinsley, et al.
Publicat: (2011-05-01)

A-utrophin up-regulation in mdx skeletal muscle is independent of regeneration.
per: Weir, A, et al.
Publicat: (2004)

Microarray analysis of mdx mice expressing high levels of utrophin: therapeutic implications for dystrophin deficiency.
per: Baban, D, et al.
Publicat: (2008)

Micro-utrophin improves cardiac and skeletal muscle function of severely affected D2/mdx mice
per: Kennedy, T, et al.
Publicat: (2018)

Utrophin in the therapy of Duchenne Muscular Dystrophy
per: Potter, A, et al.
Publicat: (2006)

A- and B-utrophin have different expression patterns and are differentially up-regulated in mdx muscle.
per: Weir, A, et al.
Publicat: (2002)

Confirmation by immunogold labeling that utrophin is localised to the normal position of dystrophin in dystrophin-negative transgenic mouse muscle
per: Cullen, M, et al.
Publicat: (2001)

Dystrophin and utrophin influence fiber type composition and post-synaptic membrane structure.
per: Rafael, J, et al.
Publicat: (2000)

Inactivation of Sirt6 ameliorates muscular dystrophy in mdx mice by releasing suppression of utrophin expression
per: Angelina M. Georgieva, et al.
Publicat: (2022-07-01)

Chronic Dosing with Membrane Sealant Poloxamer 188 NF Improves Respiratory Dysfunction in Dystrophic Mdx and Mdx/Utrophin-/- Mice.
per: Bruce E Markham, et al.
Publicat: (2015-01-01)

Prevention of the dystrophic phenotype in dystrophin/utrophin-deficient muscle following adenovirus-mediated transfer of a utrophin minigene.
per: Wakefield, P, et al.
Publicat: (2000)

Second-generation compound for the modulation of utrophin in the therapy of DMD
per: Guiraud, S, et al.
Publicat: (2015)

Evaluation of novel compounds for upregulation of utrophin in animal models of Duchenne muscular dystrophy therapy
per: Fairclough, R, et al.
Publicat: (2008)

Utrophin luciferase knock-in mouse model for in vivo assessment of drug efficacy in preclinical trials for utrophin upregulation
per: Fairclough, R, et al.
Publicat: (2010)

Metabolic profiles of dystrophin and utrophin expression in mouse models of Duchenne muscular dystrophy.
per: Griffin, J, et al.
Publicat: (2002)

New orally available compounds which modulate utrophin expression for the therapy of Duchenne muscular dystrophy (DMD)
per: Fairclough, R, et al.
Publicat: (2014)

The utrophin and dystrophin genes share similarities in genomic structure.
per: Pearce, M, et al.
Publicat: (1993)

Immunogold confirmation that utrophin is localized to the normal position of dystrophin in dystrophin-negative transgenic mouse muscle.
per: Culle, M, et al.
Publicat: (2001)

A and B utrophin in human muscle and sarcolemmal A-utrophin associated with tumours.
per: Sewry, C, et al.
Publicat: (2005)

Identification of new chemical compounds with upregulate utrophin for the therapy of Duchenne muscular dystrophy
per: Fairclough, R, et al.
Publicat: (2012)

Utrophin influences mitochondrial pathology and oxidative stress in dystrophic muscle
per: Kennedy, T, et al.
Publicat: (2017)

Understanding the endothelial function of utrophin.
per: Ehmsen, J, et al.
Publicat: (2002)

The artificial zinc finger coding gene 'Jazz' binds the utrophin promoter and activates transcription.
per: Corbi, N, et al.
Publicat: (2000)

Utrophin upregulation in DMD therapy: current status and new tools for the future
per: Fairclough, R, et al.
Publicat: (2011)

Regulation of utrophin in transgenic mice.
per: Davies, K
Publicat: (2005)

Identification of serum protein biomarkers for utrophin based DMD therapy.
per: Guiraud, S, et al.
Publicat: (2017)

The potential of utrophin and dystrophin combination therapies for Duchenne muscular dystrophy
per: Guiraud, S, et al.
Publicat: (2019)

Matricellular Protein CCN5 Gene Transfer Ameliorates Cardiac and Skeletal Dysfunction in mdx/utrn (±) Haploinsufficient Mice by Reducing Fibrosis and Upregulating Utrophin Expression
per: Min Ho Song, et al.
Publicat: (2022-04-01)

Utrophin Compensates dystrophin Loss during Mouse Spermatogenesis
per: Hung-Chih Chen, et al.
Publicat: (2017-08-01)

Utrophin influences mitochondrial pathology and oxidative stress in dystrophic muscle
per: Tahnee L. Kennedy, et al.
Publicat: (2017-10-01)

Utrophin in therapy of Duchenne muscular distrophy
per: Fisher, R
Publicat: (2001)

Testing of SHIRPA, a mouse phenotypic assessment protocol, on Dmd(mdx) and Dmd(mdx3cv) dystrophin-deficient mice.
per: Rafael, J, et al.
Publicat: (2000)

Safety, tolerability, and pharmacokinetics of SMT C1100, a 2‐arylbenzoxazole utrophin modulator, following single‐ and multiple‐dose administration to healthy male adult volunteers
per: Tinsley, J, et al.
Publicat: (2015)

Chemical proteomics and phenotypic profiling identifies the aryl hydrocarbon receptor as a molecular target of the utrophin modulator ezutromid
per: Wilkinson, IVL, et al.
Publicat: (2019)

Utrophin upregulation in Duchenne muscular dystrophy.
per: Hirst, R, et al.
Publicat: (2005)